Results 11 to 20 of about 76,842 (216)

Hospital Infection Control in Hematopoietic Stem Cell Transplant Recipients

Emerging Infectious Diseases, 2001
Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients contains a section on hospital infection control including evidence-based recommendations regarding ventilation, construction, equipment, plants, play ...
Clare A. Dykewicz
doaj   +2 more sources

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide [PDF]

, 2021
Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy.
Martino Bofarull, Rodrigo, Sierra, Jorge, Sánchez Ortega, Isabel, Esquirol, Albert, García Cadenas, Irene, Herruzo, Beatriz, Universitat Autònoma de Barcelona. Departament de Medicina, Pérez, Ariadna, Parody, Rocío, Spanish Group for Hematopoietic Stem cell Transplantation (GETH), Sanchez-Ortega, Isabel, Garcia-Cadenas, Irene, Kwon, Mi, Hernani, Rafael, Pascual, Maria Jesús, Ferra, Christelle, Dorado, Nieves, Torrent, Anna, Dorado-Herrero, Nieves, Martino, Rodrigo, Spanish Group for Hematopoietic Stem cell Transplantation (GETH)   +20 more
core   +1 more source

Mesenchymal stem cells in hematopoietic stem cell transplantation [PDF]

Cytotherapy, 2009
Mesenchymal stromal/stem cells (MSC) of bone marrow (BM) origin not only provide the supportive microenvironmental niche for hematopoietic stem cells (HSC) but are capable of differentiating into various cell types of mesenchymal origin, such as bone, fat and cartilage.
Minoo, Battiwalla, Peiman, Hematti
openaire   +2 more sources

Hematopoietic stem cell transplantation in Egypt [PDF]

Bone Marrow Transplantation, 2008
Hematopoietic SCT is now an established treatment modality with definitive indications for many hematological disorders. However, this line of treatment requires tremendous resources, and it becomes increasingly difficult for transplanters practicing in the developing world to reconcile the difference between what is possible and what is available.
Hk, Mahmoud, Am, El-Haddad, Oa, Fahmy, M, El-Emary, A, Nassar, M, Abdel-Mooti, A, Sobhy, A, Sultan   +7 more
openaire   +2 more sources

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation:a Global Observational Study [PDF]

, 2013
Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.
Madrigal, Alejandro, Horowitz, Mary, Passweg, Jakob, Bouzas, Luis Fernando, Szer, Jeff, Niederwieser, Dietger, Gratwohl, Alois, Aljurf, Mahmoud, Iida, Minako, Kodera, Yoshihisa, Worldwide Network Blood Marrow Tra, Pasquini, Marcelo C., Marrow Transplantation,, Lipton, Jeff, Worldwide Network of Blood,, Gratwohl, Michael, Baldomero, Helen, Frauendorfer, Karl   +17 more
core   +1 more source

Identification of the niche and phenotype of the first human hematopoietic stem cells [PDF]

, 2014
In various vertebrate species, the dorsal aorta (Ao) is the site of specification of adult hematopoietic stem cells (HSCs). It has been observed that the upregulation of essential hematopoietic transcription factors and the formation of specific intra ...
Stanislav Rybtsov, Anderson, Richard A., Turner, Marc L., Anderson, Richard A, Ivanovs, Andrejs, Andrejs Ivanovs, Richard A. Anderson, Turner, Marc L, Marc L. Turner, Alexander Medvinsky, Medvinsky, Alexander, Rybtsov, Stanislav   +11 more
core   +1 more source

Hematopoietic stem cell transplantation in thalassemia [PDF]

Bone Marrow Transplantation, 2008
SCT still remains the only cure currently available for patients with thalassemia. Results of transplants in this disease have steadily improved over the last two decades due to improvements in preventive strategies, effective control of transplant-related complications and development of new preparative regimens.
J, Gaziev, P, Sodani, G, Lucarelli
openaire   +2 more sources

Hematopoietic stem cells for transplantation [PDF]

Nature Immunology, 2002
Multiple sources of HSCs exist. Here, Verfaillie discusses the long-term engraftment capabilities of each source and the search for ex vivo expansion conditions to allow bulk culture for therapeutic HSC transplantation.
openaire   +3 more sources

Patient reported outcomes in view of symptom experience of late effects and self-management of adult long-term survivors after allogeneic haematopoietic stem cell transplantation - a mixed methods study [PDF]

, 2014
Even years after allogeneic stem cell transplantation, recipients face a continuing risk of developing serious late effects. Previous studies have focused on the pathophysiological understanding of late effects, as well as on treatment and disease ...
Kirsch, Monika
core   +1 more source

Hematopoietic stem cell transplantation

Stem Cells and Cloning: Advances and Applications, 2010
More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-deficiency illnesses, congenital metabolic defects, hemoglobinopathies, and myelodysplastic and myeloproliferative syndromes.
Hatzimichael,Eleftheria, Tuthill,Mark
openaire   +5 more sources